BLRX - Bioline Rx Ltd - ADR
Previous close
0.6408
0 0%
Share volume: 167,161
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.64
0.00
0.00%
Summary score
4%
Profitability
0%
Dept financing
7%
Liquidity
30%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.02%
Return on assets
-11.73%
Return on sales
0%
Return on invested capital
-121.66%
Total debt ratio
19.26%
Debt ratio change over timeo
-1.35%
Current Ratio
7.18%
Quick Ratio
0%
Cash Position Ratio
0.83%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-19.06%
Return on assets
-13.57%
Return on sales
0%
Return on invested capital
-45.42%
Total debt ratio
35.33%
Debt ratio change over timeo
-1.98%
Current Ratio
2.9%
Quick Ratio
0%
Cash Position Ratio
0.48%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-23.35%
Return on assets
-14.53%
Return on sales
0%
Return on invested capital
-50.18%
Total debt ratio
39.56%
Debt ratio change over time
-1.54%
Current Ratio
1.88%
Quick Ratio
0%
Cash Position Ratio
0.43%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-80.05%
Return on assets
-85.21%
Return on sales
0%
Return on invested capital
-0.25%
Total debt ratio
-134.92%
Debt ratio change over time
-1.35%
Current Ratio
-6.65%
Quick Ratio
0%
Cash Position Ratio
-1.77%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BLRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.02% | -0.95% | 10.89% | 6.02% |
| Return on assets | -11.73% | 3.77% | 3.55% | 5.32% |
| Return on sales | 0% | 33.63% | 42.5% | 33.22% |
| Return on invested capital | -121.66% | 5.38% | 8.18% | 11.98% |
| Profitability | 0% | 49% | 84% | 83% |
| Total debt ratio | 19.26% | 101.27% | 72.64% | 29.07% |
| Debt ratio change over time | -1.35% | 4.69% | 5.62% | 1.56% |
| Dept financing | 5% | 46% | 43% | 14% |
| Current Ratio | 2.9% | 2.09% | 2.2% | 3.95% |
| Quick Ratio | 0% | 1.98% | 1.91% | 3.21% |
| Cash Position Ratio | 0.48% | 1.5% | 0.68% | 1.67% |
| Liquididy | 41% | 31% | 49% | 61% |
| Short-term ratios | BLRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -19.06% | -26.47% | 18.76% | 5.16% |
| Return on assets | -13.57% | 4.51% | 3.92% | 4.18% |
| Return on sales | 0% | 37.94% | 39.67% | 29.9% |
| Return on invested capital | -45.42% | 9.05% | 8.77% | 11.34% |
| Profitability | 0% | 69% | 91% | 74% |
| Total debt ratio | 35.33% | 111.53% | 82.97% | 24.67% |
| Debt ratio change over time | -1.98% | -30.17% | 7.77% | 0.57% |
| Dept financing | 8% | 25% | 44% | 7% |
| Current Ratio | 2.9% | 2.09% | 2.2% | 3.95% |
| Quick Ratio | 0% | 1.98% | 1.91% | 3.21% |
| Cash Position Ratio | 0.48% | 1.5% | 0.68% | 1.67% |
| Liquididy | 26% | 51% | 39% | 75% |